Information on canceled tender procedure RFP - 024313 - Bioanalitycal method development, determination of AD-O51.4 and anti-drug antibody level in serum of patients enrolled in the clinical trial (GLP standard)

Adamed Pharma S.A. informs that, based on the pt. 1 General Provisions of the Request for Proposals, number RFP - 024313 - nr. 2022/ABM/05/00006-00 - Bioanalitycal method development, determination of AD-O51.4 and anti-drug antibody level in serum of patients enrolled in the clinical trial (GLP standard), the tender procedure is canceled.